As the Executive Director and Co-founder of ServareGMP, Gary Pierce is at the forefront of revolutionizing the development of biologics aimed at addressing some of the most pressing health challenges faced by vulnerable populations. With a deep-seated commitment to creating accessible and effective biologic medicines,...
As the Executive Director and Co-founder of ServareGMP, Gary Pierce is at the forefront of revolutionizing the development of biologics aimed at addressing some of the most pressing health challenges faced by vulnerable populations. With a deep-seated commitment to creating accessible and effective biologic medicines, ServareGMP operates as a non-profit organization, ensuring that groundbreaking therapies are available at little to no cost to those in need. Under Gary's leadership, the organization harnesses his extensive expertise in biologics development, cGMP manufacturing, and regulatory compliance to navigate the complexities of the biotech landscape.
Gary's previous success as the founder and CEO of PacificGMP, a prominent Contract Development and Manufacturing Organization (CDMO), has equipped him with invaluable insights into the intricacies of biotech startups. His experience spans over a decade, during which he oversaw the company from its inception through its successful sale in 2015. This background not only solidifies his technical acumen in biologics development and clinical trials but also enhances his strategic vision for ServareGMP.
Currently, Gary is spearheading key projects that focus on the development of vaccines and therapeutics for diseases that disproportionately affect underserved communities. His role involves complex problem-solving and business development strategies that align with the organization's mission. As Chair of the Board of Directors, he also emphasizes corporate governance, ensuring that ServareGMP adheres to the highest standards of ethical practice while fostering innovation. Through his leadership, Gary Pierce is dedicated to making a lasting impact on global health by bridging the gap between advanced biotechnology and the communities that need it most.
